{
    "eid": "2-s2.0-85082380872",
    "title": "Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Win Min Han",
        "Lalita Wattanachanya",
        "Tanakorn Apornpong",
        "Jureeporn Jantrapakde",
        "Anchalee Avihingsanon",
        "Stephen J. Kerr",
        "Nipat Teeratakulpisarn",
        "Tanate Jadwattanakul",
        "Tawatchai Chaiwatanarat",
        "Patinut Buranasupkajorn",
        "Reshmie Ramautarsing",
        "Nittaya Phanuphak",
        "Sarat Sunthornyothin",
        "Kiat Ruxrungtham",
        "Praphan Phanuphak",
        "Jintanat Ananworanich",
        "Chintana Chaturawit",
        "Pornpen Mathajittiphun"
    ],
    "citedby-count": 12,
    "ref-count": 33,
    "ref-list": [
        "Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review",
        "Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. Healthcare system",
        "Incident fractures in HIV-infected individuals: A systematic review and meta-analysis",
        "HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population-based cohort study",
        "Bones, fractures, antiretroviral therapy and HIV",
        "Long-term bone mineral density changes in Antiretroviral-Treated HIV-infected individuals",
        "Low bone mineral density in patients with well-suppressed HIV infection: Association with body weight, smoking, and prior advanced HIV disease",
        "Bone disease and HIV infection",
        "HIV infection and bone mineral density in middle-aged women",
        "Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: The global Longitudinal study of Osteoporosis in Women (GLOW)",
        "Bone disease in HIV infection: A practical review and recommendations for HIV care providers",
        "Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation",
        "Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals",
        "Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study",
        "Bone metabolism dysfunction mediated by the increase of proinflammatory cytokines in chronic HIV infection",
        "Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection",
        "Antiretroviral-naive HIV-infected patients had lower bone formation markers than HIV-uninfected adults",
        "Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study",
        "Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients",
        "Tenofovir and bone health",
        "Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen",
        "Long-term bone mineral density changes in Antiretroviral-Treated HIV-infected individuals",
        "Nomogram for derivation of renal threshold phosphate concentration",
        "Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV medicine association of the infectious diseases Society of America",
        "The diagnosis of osteoporosis",
        "Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS clinical trials group A5224s, a substudy of ACTG A5202",
        "Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: Two randomised, double-blind, phase 3, non-inferiority trials",
        "Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized trial",
        "Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial",
        "Tenofovir alafenamide versus tenofovir disoproxil fumarate in the first protease inhibitor-based single-tablet regimen for initial HIV-1 therapy: A randomized phase 2 study",
        "Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density",
        "Switching from TDF to TAF in HIV-infected adults with low BMD: A pooled analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kensington",
            "@id": "60026655",
            "affilname": "The Kirby Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "124186472",
            "affilname": "Queen Savang Vadhana Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124186472",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Chonburi",
            "@id": "111005067",
            "affilname": "Queen Savang Vadhana Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/111005067",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "HIV-NAT",
        "Queen Savang Vadhana Memorial Hospital",
        "Ratchadapiseksompotch Fund",
        "Thai Red Cross AIDS Research Centre",
        "ViiV Healthcare",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}